A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT07292714 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease COPD

Interventions

DRUG: 9MW1911
DRUG: Phase II placebo

Sponsor

Mabwell (Shanghai) Bioscience Co., Ltd.